Access cutting-edge rectal cancer treatment through this clinical trial at a research site in Commack. Study-provided care at no cost to qualified participants.
Access rectal cancer specialists in Commack at no cost
This study follows strict safety protocols and ethical guidelines
All study-related rectal cancer treatment provided free
The purpose of this study is to find out whether the combination of botensilimab and balstilimab (BOT/BAL) is a safe and effective treatment that causes few or mild side effects for people with mismatch repair proficient (MMRp)/microsatellite stable (MSS) locally advanced rectal adenocarcinoma. The investigators will also find out whether BOT/BAL is an effective treatment when given in combination with standard chemotherapy.
Sponsor: Memorial Sloan Kettering Cancer Center
Check if you qualify for this rectal cancer clinical trial in Commack, NY
If you're searching for rectal cancer treatment options in Commack, NY, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Commack research site is actively enrolling participants for this clinical trial. You'll receive care from experienced rectal cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.